Moreover, IGSF9 overexpression is also associated with poor prognosis in several other cancer types, including brain lower grade glioma, skin cutaneous melanoma, and thymoma, suggesting that the significance of IGSF9 in cancer pathology is likely not limited to endometrial cancer. This evidence concerns the gene IGSF9 and cancer.